Necessity of in Situ Hybridization Test of Human Epidermal Growth Factor Receptor 2 (HER2) Status in Breast Cancer Patients With Equivocal HER2 Immunohistochemistry Results

Journal of Breast Disease
doi 10.14449/jbd.2018.6.1.1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Korean Breast Cancer Society

Related search

Relationship Among Mammographic Findings With Histopathologic Type of Breast Cancer and Human Epidermal Growth Factor Receptor 2 (HER2) in Young Women

Electronic physician
2017English

Comparison of Immunohistochemistry and Fluorescence in Situ Hybridization for the Analysis of Her2/Neu and Topoisomerase Ii-Alpha Status in Human Breast Cancer

Turk Patoloji Dergisi
Forensic MedicinePathology
2010English

Human Epidermal Growth Factor Receptor 2 Status of Breast Cancer Patients in Asia: Results From a Large, Multicountry Study

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2016English

Review of HER2 Immunohistochemistry and in Situ Hybridisation Concordance in Breast Cancer

Pathology
Forensic MedicinePathology
2020English

Clinical Utility of Serum Human Epidermal Growth Factor Receptor Type 2 Testing as a Marker of Therapeutic Response in Tissue HER2-Positive Breast Cancer Patients

International Journal of Cancer and Clinical Research
2017English

Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Breast Cancer

Expert Opinion on Biological Therapy
Drug DiscoveryClinical BiochemistryPharmacology
2013English

High Concordance Between Immunohistochemistry and Fluorescence in Situ Hybridization Testing for HER2 Status in Breast Cancer Requires a Normalized IHC Scoring System

Modern Pathology
Forensic MedicinePathology
2008English

Validation of a New Classifier for the Automated Analysis of the Human Epidermal Growth Factor Receptor 2 (HER2) Gene Amplification in Breast Cancer Specimens

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2013English

Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines

JAMA Oncology
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy